Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease

被引:92
|
作者
Bohnen, Nicolaas I. [1 ,2 ,3 ,4 ]
Mueller, Martijn L. T. M.
Zarzhevsky, Natalia
Koeppe, Robert A.
Bogan, Christopher W.
Kilbourn, Michael R.
Frey, Kirk A. [2 ]
Albin, Roger L. [2 ,3 ,4 ]
机构
[1] Univ Michigan, Cognit & Mobil Lab, Dept Radiol, Div Nucl Med, Ann Arbor, MI 48105 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48105 USA
[3] Vet Adm Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI 48105 USA
[4] Vet Adm Ann Arbor Healthcare Syst, Ctr Geriatr Res Educ & Clin, Ann Arbor, MI 48105 USA
基金
美国国家卫生研究院;
关键词
dopamine; motor; Parkinson's disease; leucoaraiosis; magnetic resonance imaging; white matter hyperintensities; WHITE-MATTER HYPERINTENSITIES; STOOPED POSTURE; LEUKOARAIOSIS; FALLS; DISORDERS; LESIONS; GAIT; SEGMENTATION; PATHOGENESIS; EQUILIBRIUM;
D O I
10.1093/brain/awr139
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Leucoaraiosis is associated with motor symptoms in otherwise normal older adults. Comorbid leucoaraiosis is predicted to contribute also to motor features in Parkinson's disease but previous studies of white matter changes in Parkinson's disease show variable results. No prior studies have compared directly the effects of both leucoaraiosis and the degree of nigrostriatal dopaminergic denervation on motor features. We investigated the effect of leucoaraiosis severity on motor impairment independent of the degree of nigrostriatal dopaminergic denervation in Parkinson's disease. Seventy-three subjects with Parkinson's disease (Hoehn and Yahr stages 1-3) underwent brain magnetic resonance and [C-11]dihydrotetrabenazine vesicular monoamine transporter type 2 positron emission tomography imaging. Automated assessment of supratentorial fluid-attenuated inversion recovery magnetic resonance hyperintense white matter voxels was performed using cerebellar white matter as the intensity reference. White matter signal hyperintensity burden was log-transformed and normalized for brain volume. Unified Parkinson's Disease Rating Scale total and subscore ratings were assessed to determine motor impairment. Subjects receiving dopaminergic medications were examined in the clinically defined 'OFF' state. Multivariate regression analysis with measures of white matter signal hyperintensity burden and nigrostriatal denervation as independent variables demonstrated a significant overall model for total motor Unified Parkinson's Disease Rating Scale scores (F = 11.4, P < 0.0001) with significant regression effects for both white matter signal hyperintensity burden (t = 2.0, beta = 0.22, P = 0.045) and striatal monoaminergic binding (t = -3.5, beta = -0.38, P = 0.0008). Axial motor impairment demonstrated a robust association with white matter signal hyperintensity burden (t = 4.0, beta = 0.43, P = 0.0001) compared with striatal monoaminergic binding (t = -2.1, beta = 0.22, P = 0.043). White matter signal hyperintensity burden regression effects for bradykinesia had borderline significance. No significant white matter signal hyperintensity burden effects were found for rigidity or tremor subscores. White matter signal hyperintensity burden was significantly higher in the subgroup with postural instability and gait difficulties compared with the tremor-predominant subgroup despite no significant differences in age or duration of disease. These findings indicate that increased white matter signal hyperintensity burden is associated with worse motor performance independent of the degree of nigrostriatal dopaminergic denervation in Parkinson's disease. Comorbid white matter disease is a greater determinant of axial motor impairment than nigrostriatal dopaminergic denervation.
引用
收藏
页码:2358 / 2365
页数:8
相关论文
共 50 条
  • [1] Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease
    Nicolaas I. Bohnen
    Satyanarayana Gedela
    Hiroto Kuwabara
    Gregory M. Constantine
    Chester A. Mathis
    Stephanie A. Studenski
    Robert Y. Moore
    [J]. Journal of Neurology, 2007, 254 : 84 - 90
  • [2] Onset pattern of nigrostriatal denervation in early Parkinson's disease
    Pineda-Pardo, Jose A.
    Sanchez-Ferro, Alvaro
    Monje, Mariana H. G.
    Pavese, Nicola
    Obeso, Jose A.
    [J]. BRAIN, 2022, 145 (03) : 1018 - 1028
  • [3] Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease
    Bohnen, Nicolaas I.
    Gedela, Satyanarayana
    Kuwabara, Hiroto
    Constantine, Gregory M.
    Mathis, Chester A.
    Studenski, Stephanie A.
    Moore, Robert Y.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 (01) : 84 - 90
  • [4] Grooved pegboard test as a biomarker of nigrostriatal denervation in Parkinson's disease
    Bohnen, Nicolaas I.
    Kuwabara, Hiroto
    Constantine, Gregory M.
    Mathis, Chester A.
    Moore, Robert Y.
    [J]. NEUROSCIENCE LETTERS, 2007, 424 (03) : 185 - 189
  • [5] Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson’s disease
    Agostino Chiaravalloti
    Alessandro Stefani
    Daniele Di Biagio
    Mariangela Pierantozzi
    Mario Tavolozza
    Barbara Di Pietro
    Paolo Stanzione
    Orazio Schillaci
    [J]. Annals of Nuclear Medicine, 2013, 27 : 444 - 451
  • [6] Correlation study between nigrostriatal denervation and pain in Parkinson's disease
    Dellapina, E.
    Ory-Magne, F.
    Harroch, E.
    Payoux, P.
    Brefel-Courbon, C.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S295 - S295
  • [7] Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease
    Chiaravalloti, Agostino
    Stefani, Alessandro
    Di Biagio, Daniele
    Pierantozzi, Mariangela
    Tavolozza, Mario
    Di Pietro, Barbara
    Stanzione, Paolo
    Schillaci, Orazio
    [J]. ANNALS OF NUCLEAR MEDICINE, 2013, 27 (05) : 444 - 451
  • [8] Correlation study between nigrostriatal denervation and pain in Parkinson's disease
    Dellapina, E.
    Ory-Magne, F.
    Harroch, E.
    Payoux, P.
    Brefel-Courbon, C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 7 - 7
  • [9] White Matter Lesions Augment Motor Impairments of Nigrostriatal Dopaminergic Denervation in Parkinson Disease
    Albin, Roger L.
    Muller, Martijn T.
    Bogan, Christopher W.
    Koeppe, Robert A.
    Kilbourn, Michael R.
    Frey, Kirk A.
    Bohnen, Nicolaas I.
    [J]. NEUROLOGY, 2010, 74 (09) : A500 - A500
  • [10] Non-motor symptoms of Parkinson's disease and nigrostriatal dopaminergic degeneration: a study with Datscan
    Todorova, A.
    Buxton-Thomas, M.
    Chaudhuri, K. Ray
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S133 - S133